18F-Fluciclovine PET Imaging for Detecting High Grade Glioma Recurrence After Radiochemotherapy
Status:
Not yet recruiting
Trial end date:
2023-12-31
Target enrollment:
Participant gender:
Summary
This study will examine whether positron emission tomography (PET) imaging with fluciclovine
can reliably differentiate true progression from pseudoprogression months earlier than the
conventional MRI methods.
Phase:
Phase 3
Details
Lead Sponsor:
Nicole Hill
Collaborators:
Barrow Neurological Foundation Blue Earth Diagnostics